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PRELIMINARY AND SHORT REPORT
OXIDATIVE METABOLISM IN PERFUSED SURVIVING DOG SKIN*
ROBERT L. BELL, M.D.1, ROBERT LUNDQUIST, M.D. AND KENNETH M. HALPRIN, M.D.
In 1954, Kjaersgaard (1) described a technic
for perfusion of surviving dog skin. The saphenous
artery leading to the skin of the medial aspect of
the upper hind limb of a dog is cannulated and the
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which humidity and temperature can be con-
trolled. Any desired solution can then be perfused
through the arterial cannula and the effluent solu-
tion collected from the venous side. This method
FIG. 1. Radioactive carbon dioxide in venous effluent from dog skin continuously perfused with blood
which for an initial period contained radio-carbon-labelled acetate.
skin area supplied by this artery is separated
from the underlying tissue. The saphenous vein
is likewise cannulated and the skin is excised and
placed into a specially prepared perfusion box in
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is applicable to three types of studies: 1. deter-
mination of the metabolism of a particular sub-
stance by analysis of the effluent venous solution
for metabolic products of a material infused
through the arterial end; 2. analysis of the skin
itself for determination of incorporation into
skin constituents of a material infused through
the arterial end; and 3. analysis of the effluent
blood or parts of the skin itself after surface appli-
cation of a particular substance to determine its
13
absorption through, or into, the skin.
As a study preliminary to investigation of the
oxidative metabolism of dog skin, the ability of
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such skins to survive and actively metabolize
was studied. Radioactive carbon (14) acetate in
heparinized dog blood was perfused through the
arterial end and the effluent venous blood was
analyzed for radioactive carbon dioxide. Radio-
active carbon dioxide appeared in the venous
blood within ten minutes after starting the per-
fusion and reached a peak value in approximately
one-half hour. Substituting non-radioactive blood
at this point lead to an asymptotic decrease in the
level of radioactive carbon dioxide emerging, a
plateau being reached within three to four hours
(Fig. 1).
Such preparations can also be seen to actively
utilize oxygen by comparison of the color of the
'arterial' and 'venous' blood. The former is pink-
red while the latter is a very dark red. Skin per-
fusions carried on for as long as 18 hours have con-
tinued to show this color change.
Skin removed from the dog and kept in cold
saline under refrigeration for 24 hours can still be
perfused providing the arterial end has been in-
jected with heparin to prevent clotting. There is
no apparent loss of oxidative ability under these
conditions.
CONCLUSION
These results indicate that surviving dog skin
retains its oxidative abilities for at least 18 hours
under conditions simulating those normally
occurring. Such preparations actively metabolize
acetate to carbon dioxide, thereby demonstrat-
ing an intact oxidative pathway able to utilize
acetate as a substrate and presumably yielding
high amounts of energy from this transformation.
Further studies are now being carried on to de-
terinine the intermediate steps in this pathway.
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